- #Iom national academies press how to
- #Iom national academies press professional
- #Iom national academies press free
In addition, the current system for financing accredited continuing medical education relies too heavily on industry support and needs to be overhauled to be free of industry influence and provide high-quality education. Groups that develop guidelines should not accept direct industry funding for this work and generally should exclude individuals with conflicts of interest from the panels that draft guidelines, the report says.
#Iom national academies press how to
Greater transparency and accountability are needed in the development of clinical practice guidelines, which advise physicians on how to best provide care.
#Iom national academies press professional
Several professional organizations and industry groups have set new limits on gift giving and other relationships between industry and the medical community, but it is too soon to gauge the effects these changes, the committee noted. Physicians should limit their interactions with company sales representatives and use free drug samples only for patients who cannot afford medications. Consulting arrangements should be limited to legitimate expert services spelled out in formal contracts and paid for at a fair market rate. The report calls on researchers, medical school faculty, and private-practice doctors to forgo gifts of any amount from medical companies and to decline to publish or present material ghostwritten or otherwise controlled by industry. It also would provide medical institutions with a way to verify the accuracy of information that physicians, researchers, and senior officials have disclosed to them.
A public record like this could serve as a deterrent to inappropriate relationships and undue industry influence. In addition, Congress should require pharmaceutical, biotechnology, and device firms to report through a public Web site the payments they make to doctors, researchers, academic health centers, professional societies, patient advocacy groups, and others involved in medicine. The format for disclosure and categories of relationships should be standardized to help institutions judge the risk that a relationship poses and to ease the burden for individuals who must report information to multiple organizations with different policies. The committee noted substantial variations in institutions' conflict-of-interest policies and shortcomings in physicians' and researchers' adherence to policy requirements. Disclosure by physicians and researchers not only to their employers but also to other medical organizations of their financial links to pharmaceutical, biotechnology, and medical device firms is an essential first step in identifying and managing conflicts of interest and needs to be improved. This report spells out a strategy to protect against financial conflicts while allowing productive relationships between the medical community and industry that contribute to improved medical knowledge and care."Īll academic medical centers, journals, professional societies, and other entities engaged in health research, education, clinical care, and development of practice guidelines should establish or strengthen conflict-of-interest policies, the report says. "We also need more specific disclosure of the financial relationships that doctors and researchers have with medical industries. "It is time to end a number of long-accepted practices that create unacceptable conflicts of interest, threaten the integrity of the medical profession, and erode public trust while providing no meaningful benefits to patients or society," said Bernard Lo, chair of the committee that wrote the report and professor of medicine and director of the program in medical ethics, University of California, San Francisco. It recommends several actions to improve disclosure of financial ties between the medical community and industry, limit company payments and gifts, and remove industry influence from medical education and the development of practice guidelines.
The report tackles conflicts of interest across the spectrum of medicine, from biomedical research to clinical care and from the training of new doctors to the continuing education of physicians.
WASHINGTON - New voluntary and regulatory measures can strengthen protections against financial conflicts of interest in medicine without hindering patient care or the advancement of medical knowledge, says a new report by the Institute of Medicine. Voluntary and Regulatory Measures Needed to ReduceĬonflicts of Interest in Medical Research, Education, and Practice Contacts: Christine Stencel, Senior Media Relations OfficerĪlison Burnette, Media Relations Assistant
0 kommentar(er)
